Article

Effect of prebiotics on biomarkers of colorectal cancer in humans: A systematic review

Department of Food Science and Nutrition, University of Minnesota, Saint Paul, Minnesota 55108, USA.
Nutrition Reviews (Impact Factor: 6.08). 08/2012; 70(8):436-43. DOI: 10.1111/j.1753-4887.2012.00495.x
Source: PubMed

ABSTRACT

Prebiotics may prevent colorectal cancer (CRC) development in humans by modifying the composition or activity of the colorectal microflora. Epidemiologic and animal studies have shown a reduction in CRC or CRC biomarkers after the administration of prebiotics. Studies using indirect chemical biomarkers of CRC in humans, however, gave mixed results. Recently, human studies measuring direct physical indices of CRC risk after prebiotic consumption have been published. The purpose of this review is to summarize those studies to provide recommendations for the use of prebiotics in CRC risk reduction. A PubMed search was conducted, revealing nine studies. One tested lactulose, two evaluated a blend of oligofructose and inulin, and six measured resistant starch. Lactulose reduced adenoma recurrence, while resistant starch had no effect on adenoma or CRC development. Crypt mitotic location, gene expression, and DNA methylation were somewhat improved after resistant starch consumption. No changes in cell proliferation and apoptosis, crypt morphology, or aberrant crypt foci were found. More human studies measuring physical changes to the gut are needed.

Download full-text

Full-text

Available from: Joanne Slavin, May 21, 2015
  • Source
    • "Table 4outlines mechanisms of prebiotic effects6768697071727374. Table 5summarizes clinical conditions where prebiotics have been used. In general, the effects are less robust than for probiotics but there are also fewer clinical trials75767778798081828384858687888990. Table 4. Several functions ascribed to prebiotics which may be beneficial to the host. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dairy foods contain complex nutrients which interact with the host. Yet, evolution of lactase persistence has divided the human species into those that can or cannot digest lactose in adulthood. Such a ubiquitous trait has differential effects on humanity. The literature is reviewed to explore how the divide affects lactose handling by lactase non persistent persons. There are two basic differences in digesters. Firstly, maldigesters consume less dairy foods, and secondly, excess lactose is digested by colonic microflora. Lactose intolerance in maldigesters may occur with random lactose ingestion. However, lactose intolerance without maldigestion tends to detract from gaining a clear understanding of the mechanisms of symptoms formation and leads to confusion with regards to dairy food consumption. The main consequence of intolerance is withholding dairy foods. However, regular dairy food consumption by lactase non persistent people could lead to colonic adaptation by the microbiome. This process may mimic a prebiotic effect and allows lactase non persistent people to consume more dairy foods enhancing a favorable microbiome. This process then could lead to alterations in outcome of diseases in response to dairy foods in lactose maldigesters. The evidence that lactose is a selective human prebiotic is reviewed and current links between dairy foods and some diseases are discussed within this context. Colonic adaptation has not been adequately studied, especially with modern microbiological techniques.
    Full-text · Article · Aug 2015 · Nutrients
  • Source
    • "Inulin, the main commercial fructan polymer, consists of a linear chain of beta 2-1 linked fructosyl units with a single terminal glucose. Inulin is used by the food industry as fat replacer (Arcia et al. 2011; Nowak et al. 2007) or low calories sweetener depending on the length of inulin molecules , while the pharmaceutical industry exploits its health promoting properties (Clark et al. 2012; Closa-Monasterolo et al. 2013; Di Bartolomeo et al. 2013). Average inulin polymerization degree (DP) varies between species, but also according to developmental stage and environmental conditions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Key message Nucleotidic polymorphisms were identified in fructan exohydrolases genes which are statistically associated with enhanced susceptibility to post-harvest inulin depolymerization. Abstract Industrial chicory (Cichorium intybus L.) root is the main commercial source of inulin, a linear fructose polymer used as dietary fiber. Post-harvest, inulin is depolymerized into fructose which drastically increases processing cost. To identify genetic variations associated with enhanced susceptibility to post-harvest inulin depolymerization and related free sugars content increase, we used a candidate-gene approach focused on inulin and sucrose synthesis and degradation genes, all members of the family 32 of glycoside hydrolases (GH32). Polymorphism in these genes was first investigated by carrying out EcoTILLING on two groups of chicory breeding lines exhibiting contrasted response to post-harvest inulin depolymerization. This allowed the identification of polymorphisms significantly associated with depolymerization in three fructan exohydrolase genes (FEH). This association was confirmed on a wider panel of 116 unrelated families in which the FEH polymorphism explained 35 % of the post-harvest variance for inulin content, 36 % of variance for sucrose content, 18 % for inulin degree of polymerization, 23 % for free fructose content and 22 % for free glucose content. These polymorphisms were associated with significant post-harvest changes of inulin content, inulin chain length and free sugars content.
    Full-text · Article · Oct 2013 · Theoretical and Applied Genetics
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Colorectal cancer (CRC) is the third most common form of human cancer. Diverse therapies such as surgery and chemotherapy have shown excellent results in CRC. However, they still have limitations. There is a need to develop new CRC treatment strategies. Probiotic formulations have shown excellent promises in CRC as modest, preventive and early stage therapeutics. This review summarizes the recent development of probiotics in CRC and highlights the importance of the intestinal microbiota balance in CRC, cover current research on probiotics for CRC prevention and treatment with emphasis on the mechanisms involved. Specifically, this report describes evidences on the role of probiotics in inhibiting tumor progression, in reducing oxidative stress, in reducing colon cell DNA damage, in producing anti-cancer compounds, in improving the microflora balance, in stimulating the host immune response and in other physiochemical conditions of the gut. Even though, some of these effects were observed in several human trials when probiotics formulations were used as a supplement with CRC therapies, the application of probiotics as a biotherapeutic against CRC still needs further investigations.
    Preview · Article · Apr 2013 · Journal of Medical Microbiology
Show more